These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20693762)

  • 1. [Treatment strategy for childhood and adolescent acute lymphoblastic leukemia in first remission].
    Hori H
    Rinsho Ketsueki; 2010 Jul; 51(7):454-9. PubMed ID: 20693762
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
    Takeuchi J
    Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic.
    Stary J; Jabali Y; Trka J; Hrusak O; Gajdos P; Hrstkova H; Sterba J; Blazek B; Hak J; Prochazkova D; Cerna Z; Smisek P; Sedlacek P; Vavra V; Mihal V; Hrodek O;
    Leukemia; 2010 Feb; 24(2):425-8. PubMed ID: 20016535
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98.
    Stark B; Nirel R; Avrahami G; Abramov A; Attias D; Ballin A; Bielorai B; Burstein Y; Gavriel H; Elhasid R; Kapelushnik J; Sthoeger D; Toren A; Wientraub M; Yaniv I; Izraeli S
    Leukemia; 2010 Feb; 24(2):419-24. PubMed ID: 20016534
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K;
    Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
    Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.
    de Bont JM; Holt Bv; Dekker AW; van der Does-van den Berg A; Sonneveld P; Pieters R
    Leukemia; 2004 Dec; 18(12):2032-5. PubMed ID: 15483674
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
    Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
    Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Towards cure for all children with acute lymphoblastic leukemia?].
    Baruchel A; Leblanc T; Auclerc MF; Schaison G; Leverger G
    Bull Acad Natl Med; 2009 Oct; 193(7):1509-17. PubMed ID: 20669632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
    Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
    Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
    Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
    Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology and therapy of childhood acute lymphoblastic leukemia.
    Rivera GK; Crist WM; Sallan SE
    Rev Invest Clin; 1994 Apr; Suppl():26-33. PubMed ID: 7886304
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment strategy for adult acute lymphoblastic leukemia].
    Okamoto S
    Rinsho Ketsueki; 2002 Jun; 43(6):427-32. PubMed ID: 12134694
    [No Abstract]   [Full Text] [Related]  

  • 14. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
    J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].
    Doubek M; Mayer J; Korístek Z; Protivánková M; Brychtová Y; Oborilová A; Král Z; Klabusay M; Tomíska M; Buchtová I; Vorlícek J
    Cas Lek Cesk; 2002 Mar; 141(4):122-6. PubMed ID: 12046256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
    Liu Z; Liu XL; Du QF; Xu N; Zhong M; Song LL; Yi ZS; Liu QF; Meng FY; Zhou SY
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):512-5. PubMed ID: 19304540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
    Herold R; von Stackelberg A; Hartmann R; Eisenreich B; Henze G
    J Clin Oncol; 2004 Feb; 22(3):569-70; author reply 570-1. PubMed ID: 14752084
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuing chemoimmunotherapy in childhood acute lymphoblastic leukemia.
    Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
    Biomed Pharmacother; 1988; 42(9):597-603. PubMed ID: 3240364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.